Evidence map›Paper›PMID 28913757›Full record

ArticleFolia microbiologica2018

Mycobacterium shimoidei-cavitary pulmonary disease with favorable outcome.

Vide Popovic, Dragan Arar, Dragica Roso Popovic, Igor Barisic, Marija Tonkic, Irena Peric, Anita Novak, Zana Rubic, Vera Katalinic-Jankovic, Mateja Jankovic Makek and 1 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Folia microbiologica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Journal of clinical tuberculosis and other mycobacterial diseases · 2025
    Article
  2. Is Mycobacterium shimoidei an under-recognized cause of tuberculosis-like disease?Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Article
  3. Article
  4. BMJ case reports · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Vide PopovicClinic for Respiratory Disease, University Hospital of Split, Split, Croatia.
Dragan ArarClinic for Respiratory Disease, University Hospital of Split, Split, Croatia.
Dragica Roso PopovicClinic for Internal Medicine, University Hospital of Split, Split, Croatia.
Igor BarisicUniversity of Split School of Medicine, Split, Croatia.
Marija TonkicUniversity of Split School of Medicine, Split, Croatia.
Irena PericClinic for Respiratory Disease, University Hospital of Split, Split, Croatia.
Anita NovakUniversity of Split School of Medicine, Split, Croatia.
Zana RubicUniversity of Split School of Medicine, Split, Croatia.
Vera Katalinic-JankovicNRL for Tuberculosis (SNRL-WHO), Croatian National Institute of Public Health, Zagreb, Croatia.
Mateja Jankovic MakekClinic for Respiratory Disease, University Hospital Centre Zagreb, Zagreb, Croatia.
Ivana Goic-BarisicUniversity of Split School of Medicine, Split, Croatia. igoic@kbsplit.hr.
University of Split · HRUniversity Hospital Centre Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of cavitary pulmonary disease caused by Mycobacterium shimoidei in 67-year-old female with history of asthma. Even though susceptibility testing was not available, choice of treatment regimen (streptomycin, rifampicin, ethambutol, and clarithromycin), based on a few cases with favorable outcome reported in the literature, resulted with an excellent clinical, microbiological, and radiological response. This is the first report of pulmonary disease caused by M. shimoidei, but also the first ever isolation of M. shimoidei in Croatia.

Indexed as

AgedAnti-Bacterial AgentsClarithromycinCroatiaFemaleHumansLung DiseasesMycobacterium Infections, NontuberculousNontuberculous MycobacteriaRifampinStreptomycinTreatment OutcomeAnti-Bacterial AgentsClarithromycinRifampinStreptomycin

Identifiers

PMID28913757
OpenAlexW2755527616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.